(Q34300411)

1 August 2017

1 reference

title

Current options for the prevention and treatment of migraine (English)

1 reference

1 August 2017

1 reference

Adelman JU

1

1 reference

1 August 2017

Adelman RD

series ordinal

2

1 reference

1 August 2017

publication date

1 June 2001

1 reference

1 August 2017

published in

Clinical Therapeutics

1 reference

1 August 2017

volume

23

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

772-88; discussion 771

1 reference

Canadian Association of Emergency Physicians Guidelines for the acute management of migraine headache.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

An overview of the diagnosis and pharmacologic treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

The family history of migraine. Direct versus indirect information.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

A nosographic analysis of the migraine aura in a general population.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Medication-induced headache: overview and systematic review of therapeutic approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Randomised double-blind placebo-controlled trial of feverfew in migraine prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Magnesium in the prophylaxis of migraine--a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Feverfew as a preventive treatment for migraine: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

1 reference

7 January 2021

Migraine prophylactic drugs: proof of efficacy, utilization and cost

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical setting.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Divalproex sodium in migraine prophylaxis: a dose-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Efficacy of gabapentin in migraine prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

1 reference

7 January 2021

Rizatriptan in the treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Naratriptan: an alternative for migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

How to assess and compare drugs in the management of migraine: success rates in terms of response and recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Intravenous chlorpromazine vs intravenous metoclopramide in acute migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Triptans and migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of acetaminophen, aspirin, and caffeine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Acute Treatment of Migraine Attacks: Efficacy and Safety of A Nonsteroidal Anti-Inflammatory Drug, Diclofenac-Potassium, in Comparison To Oral Sumatriptan and Placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

A practical guide to the management and prevention of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Prevention of migraine during prodrome with naratriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

Symptomatic pharmacotherapy of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980069-2

7 January 2021

10.1016/S0149-2918(01)80069-2

Identifiers

DOI

1 reference

release_w33g5grm3bdxlalb2bu52bshqy

1 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w33g5grm3bdxlalb2bu52bshqy

24 November 2022

mapped directly with Wikidata item

1 reference